RU95110110A - Производные бензофурана, способ их получения, фармкомпозиция и способ лечения - Google Patents

Производные бензофурана, способ их получения, фармкомпозиция и способ лечения

Info

Publication number
RU95110110A
RU95110110A RU95110110/04A RU95110110A RU95110110A RU 95110110 A RU95110110 A RU 95110110A RU 95110110/04 A RU95110110/04 A RU 95110110/04A RU 95110110 A RU95110110 A RU 95110110A RU 95110110 A RU95110110 A RU 95110110A
Authority
RU
Russia
Prior art keywords
benzofuran
derivatives
pharmcomposition
synthesis
treatment
Prior art date
Application number
RU95110110/04A
Other languages
English (en)
Russian (ru)
Inventor
Чарльз Норт Петер
Gb]
Николас Вадман Сьерд
Nl]
Original Assignee
Глэксо Груп Лимитед (GB)
Глэксо Груп Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Глэксо Груп Лимитед (GB), Глэксо Груп Лимитед filed Critical Глэксо Груп Лимитед (GB)
Publication of RU95110110A publication Critical patent/RU95110110A/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/04—Nitro compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Furan Compounds (AREA)
RU95110110/04A 1992-10-16 1993-10-14 Производные бензофурана, способ их получения, фармкомпозиция и способ лечения RU95110110A (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9221761.1 1992-10-16
GB929221761A GB9221761D0 (en) 1992-10-16 1992-10-16 Chemical compounds

Publications (1)

Publication Number Publication Date
RU95110110A true RU95110110A (ru) 1996-12-27

Family

ID=10723562

Family Applications (1)

Application Number Title Priority Date Filing Date
RU95110110/04A RU95110110A (ru) 1992-10-16 1993-10-14 Производные бензофурана, способ их получения, фармкомпозиция и способ лечения

Country Status (24)

Country Link
US (1) US5494910A (enExample)
EP (1) EP0664804A1 (enExample)
JP (1) JPH06211842A (enExample)
KR (1) KR940009179A (enExample)
CN (1) CN1092420A (enExample)
AP (1) AP425A (enExample)
AU (1) AU5333794A (enExample)
CA (1) CA2146569A1 (enExample)
CZ (1) CZ96895A3 (enExample)
EC (1) ECSP941050A (enExample)
FI (1) FI951798A7 (enExample)
GB (1) GB9221761D0 (enExample)
HU (1) HUT72752A (enExample)
IL (1) IL107302A0 (enExample)
IS (1) IS4081A (enExample)
MX (1) MX9306394A (enExample)
NO (1) NO951433D0 (enExample)
PE (1) PE51294A1 (enExample)
PL (1) PL308357A1 (enExample)
RU (1) RU95110110A (enExample)
SI (1) SI9300542A (enExample)
TW (1) TW262473B (enExample)
WO (1) WO1994008993A1 (enExample)
ZA (1) ZA937633B (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9407447D0 (en) * 1994-04-14 1994-06-08 Glaxo Group Ltd Chemical compounds
EP0759918A1 (en) * 1994-05-19 1997-03-05 MERCK SHARP & DOHME LTD. Piperazine, piperidine and tetrahydropyridine derivatives of indol-3-ylalkyl as 5-ht1d-alpha agonists
GB9610979D0 (en) * 1996-05-24 1996-07-31 Merck Sharp & Dohme Therapeutic agents
JP2001501946A (ja) * 1996-10-08 2001-02-13 イーライ・リリー・アンド・カンパニー 新規セロトニン5―ht▲下1f▼アゴニスト
US5891885A (en) * 1996-10-09 1999-04-06 Algos Pharmaceutical Corporation Method for treating migraine
US20030017175A1 (en) * 2001-07-05 2003-01-23 R.T. Alamo Ventures I, Inc. Sublingual administration of dihydroergotamine for the treatment of migraine
US20030198669A1 (en) * 2001-07-05 2003-10-23 R.T. Alamo Ventures I, Llc Compositions and methods for rapid dissolving formulations of dihydroergotamine and caffeine for the treatment of migraine
US6685951B2 (en) 2001-07-05 2004-02-03 R. T. Alamo Ventures I, Inc. Administration of dihydroergotamine as a sublingual spray or aerosol for the treatment of migraine
DK2734634T3 (da) 2011-07-22 2019-10-21 Univ Chicago Igf-1 til anvendelse til behandling af migræne
KR101443041B1 (ko) * 2013-05-06 2014-09-23 (주)하이레벤 태양광 발전설비의 효율향상설비
WO2023018864A1 (en) 2021-08-12 2023-02-16 Psilosterics, Llc Hallucinogenic and non-hallucinogenic serotonin receptor agonists and methods of making and using the same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1670105A1 (de) * 1966-07-08 1970-12-10 Byk Gulden Lomberg Chem Fab Verfahren zur Herstellung von Benzofuryl (3)-alkylaminen und deren Salzen
EP0398413A1 (en) * 1989-05-16 1990-11-22 Duphar International Research B.V "3,4-dehydropiperidine derivatives having psychotropic activity

Also Published As

Publication number Publication date
AU5333794A (en) 1994-05-09
CN1092420A (zh) 1994-09-21
ZA937633B (en) 1994-08-01
SI9300542A (en) 1994-06-30
KR940009179A (ko) 1994-05-20
HUT72752A (en) 1996-05-28
HU9501073D0 (en) 1995-06-28
IL107302A0 (en) 1994-01-25
NO951433L (no) 1995-04-12
WO1994008993A1 (en) 1994-04-28
US5494910A (en) 1996-02-27
NO951433D0 (no) 1995-04-12
AP425A (en) 1995-11-08
ECSP941050A (es) 1994-11-16
PE51294A1 (es) 1995-01-06
MX9306394A (es) 1994-05-31
GB9221761D0 (en) 1992-12-02
FI951798A0 (fi) 1995-04-13
CZ96895A3 (en) 1995-12-13
CA2146569A1 (en) 1994-04-28
IS4081A (is) 1994-04-17
EP0664804A1 (en) 1995-08-02
FI951798L (fi) 1995-04-13
TW262473B (enExample) 1995-11-11
FI951798A7 (fi) 1995-04-13
JPH06211842A (ja) 1994-08-02
PL308357A1 (en) 1995-07-24
AP9300581A0 (en) 1993-10-31

Similar Documents

Publication Publication Date Title
UA41297C2 (uk) Похідні індолу, фармацевтична композиція і спосіб лікування
SE8300736D0 (sv) Novel pharmacologically active compounds
PL315636A1 (en) Cosmetic or pharmaceutic compositions containing magnipherine or its derivatives
RU94029662A (ru) Фосфонооксиметиловые эфиры производных таксана, фармацевтическая композиция, способы лечения
FI872864A0 (fi) Menetelmä farmaseuttisesti aktiivisten bentsimidatsolijohdannaisten valmistamiseksi
DE3581699D1 (de) Bis-dimethoxymethyl(trimethoxybenzyl)isochinolinium-salze, ihre herstellung und diese enthaltende pharmazeutische zusammensetzungen.
NZ240230A (en) Mercaptoacetylamide derivatives; preparation, use and pharmaceutical compositions thereof
ES2158537T3 (es) Derivados de acidos ciclopropilalcanoicos.
RU95106362A (ru) Производные липопептида, способ их получения, содержащая их фармацевтическая композиция и способ ее получения
RU93004793A (ru) Производные хиназолина, способ их получения, фармацевтическая композиция на их основе
RU94036448A (ru) Производные галантамина и фармацевтическая композиция
KR890700125A (ko) 신규 벤즈이미다졸 유도체, 그 제조방법 및 이 화합물을 함유하는 제약 조성물
UA34416C2 (uk) Похідні хроману, активні стосовно 5-нт рецептора, спосіб їх одержання та проміжні сполуки
MX9203417A (es) Compuestos de diarilo antiateroescleroticos.
RU95111308A (ru) Производные 2-амино-4-фенил-4-оксомасляной кислоты, способы получения, фармацевтическая композиция
RU93004860A (ru) Гетероциклические соединения, способ их получения, использование и фармацевтическая композиция
MD1560F2 (en) Cyclic compounds, pharmaceutical compositions on base thereof and methods of treatment of infections or diseases provoked by retroviruses.
YU242789A (en) New compound, 4-fluoro-2-//(4-metoxy-2-pyridin-yl)methylsulphinyl/-1h-benzimidazole and process for obtaining
DE69330601D1 (de) Serotoninergische ergolin derivate
RU95107655A (ru) Глюкопиранозидбензотиофены, способ получения, фармацевтическая композиция
NO950177L (no) Farmakologisk aktive erivater
AP9801235A0 (en) Erythromycin derivatives.
SE9203824L (sv) Bensofuranylimidazol-derivat, foerfarande foer framstaellning daerav och terapeutiska kompositioner innehaallande desamma
RU94046312A (ru) Применение биологически активных уреидопроизводных для лечения индуцируемых лентивирусами заболеваний, продукты, содержащие уреидопроизводные
ES2059572T3 (es) Derivado del antibiotico a 42867.